Catalent
CTLT
#1589
Rank
ยฃ8.59 B
Marketcap
ยฃ47.34
Share price
1.12%
Change (1 day)
48.30%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ3.92 Billion

According to Catalent's latest financial reports the company's total debt is ยฃ3.92 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30ยฃ3.85 B10.86%
2022-06-30ยฃ3.47 B47.7%
2021-06-30ยฃ2.35 B-4.5%
2020-06-30ยฃ2.46 B5.69%
2019-06-30ยฃ2.33 B13.15%
2018-06-30ยฃ2.06 B28.89%
2017-06-30ยฃ1.59 B15.69%
2016-06-30ยฃ1.38 B15.57%
2015-06-30ยฃ1.19 B-24.87%
2014-06-30ยฃ1.59 B-10.06%
2013-06-30ยฃ1.76 B3.44%
2012-06-30ยฃ1.71 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ30.27 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.26 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.92 B 25.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ0.17 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA